Michael Severino - May 23, 2022 Form 4 Insider Report for AbbVie Inc. (ABBV)

Role: Vice Chairman
Signature: Steven L. Scrogham, attorney-in-fact for Michael Severino
Stock symbol: ABBV
Transactions as of: May 23, 2022
Transactions value $: -$12,041,780
Form type: 4
Date filed: 5/25/2022, 04:58 PM
Previous filing: May 18, 2022
Next filing: May 15, 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABBV	Common Stock, $0.01 par value	Options Exercise	$5.3M	+46.3K	+30.45%	$114.36	198K	May 23, 2022	Direct
transaction	ABBV	Common Stock, $0.01 par value	Options Exercise	$1.1M	+11.7K	+5.92%	$93.50	210K	May 23, 2022	Direct
transaction	ABBV	Common Stock, $0.01 par value	Options Exercise	$2.3M	+21.7K	+10.34%	$105.92	232K	May 23, 2022	Direct
transaction	ABBV	Common Stock, $0.01 par value	Sale	-$10.3M	-68.2K	-29.41%	$150.79	164K	May 23, 2022	Direct	F1
transaction	ABBV	Common Stock, $0.01 par value	Sale	-$1.76M	-11.6K	-7.09%	$151.53	152K	May 23, 2022	Direct	F2

Showing 1 to 5 of 5 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ABBV	Option (Right to Buy)	Options Exercise	-$5.3M	-46.3K	-100%	$114.36	0	May 23, 2022	Common Stock	46.3K	$114.36	Direct	F3
transaction	ABBV	Option (Right to Buy)	Options Exercise	-$1.1M	-11.7K	-23.52%	$93.50	38.2K	May 23, 2022	Common Stock	11.7K	$93.50	Direct	F3
transaction	ABBV	Option (Right to Buy)	Options Exercise	-$2.3M	-21.7K	-33.33%	$105.92	43.5K	May 23, 2022	Common Stock	21.7K	$105.92	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.13 to $151.12 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.13 to $151.58 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3	Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

The option exercise and sale transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).